Last Posted: Jul 05, 2020
- Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
V Silvestri et al, JAMA Oncology, July 2, 2020 - Clinical outcomes of a genomic screening program for actionable genetic conditions
AH Buchanan et al, Genetics in Medicine, June 30, 2020 - Comparison of suspected Lynch syndrome patients carrying BRCA and BRCA-like variants with Lynch syndrome probands: Phenotypic characteristics and pedigree analyses.
Xu Yun et al. Molecular genetics & genomic medicine 2020 Jun e1359 - Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome.
De Simone Lenika M et al. Journal of genetic counseling 2020 Jun - Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.
Li Dan et al. Breast cancer (Tokyo, Japan) 2020 Jun - BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients.
Manchana Tarinee et al. Gynecologic oncology reports 2020 Aug 33100582 - Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among high risk breast Cancer patients: a retrospective chart review study.
Bobbili Priyanka et al. Hereditary cancer in clinical practice 2020 1813 - Beneficial Molecular Adaptations In BRCA -Mutation Carriers By Combined HIT/HIRT Intervention: Results From A Pilot Study.
Bizjak Daniel A et al. Cancers 2020 Jun 12(6) - Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study.
Isselhard A et al. Trials 2020 Jun 21(1) 501 - Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.
Bayraktar Soley et al. The breast journal 2020 Jun
.png)
No hay comentarios:
Publicar un comentario